A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

Classical CRISPR systems use molecular scissors to snip through DNA ... pulmonary arterial hypertension and HIV, as well as ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Gilead (GILD) delivered earnings and revenue surprises of +14.88% and +4.16%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

HOUSTON, Texas (KTRK) -- Laughter echoes through the kitchen as two friends take turns preparing lunch, injecting a few playful jokes into an already spirited conversation. On this particular day, ...

Acuitas Therapeutics recently announced the publication of a new study inMolecular Therapy - Nucleic Acids, titled "mRNA-LNP ...